Advanced search
Publication Cover
Leukemia & Lymphoma Volume 49, 2008 - Issue 10
Submit an article Journal homepage
142
Views
21
CrossRef citations to date
0
Altmetric
Letters to the Editor

Bortezomib, doxorubicin and dexamethasone association is an effective option for plasma cell leukemia induction therapy

Chadi Al-Nawakil Faculté de Médecine René Descartes, Université Paris Descartes; Service de Médecine Interne, UF d'HématologieCorrespondence[email protected]
,
Jerome Tamburini Faculté de Médecine René Descartes, Université Paris Descartes; Service de Médecine Interne, UF d'Hématologie
,
Valerie Bardet Faculté de Médecine René Descartes, Université Paris Descartes; Service d'Hématologie Biologique, Hôpital Cochin, Paris, France
,
Nicolas Chapuis Faculté de Médecine René Descartes, Université Paris Descartes; Service d'Hématologie Biologique, Hôpital Cochin, Paris, France
,
Edward Bourry Université Paris VI; Service de néphrologie, Hôpital Pitié-Salpêtrière, Paris, France
,
Christian Roux Faculté de Médecine René Descartes, Université Paris Descartes; Service de Rhumatologie, Hôpital Cochin, ParisFrance
,
Sophie Park Faculté de Médecine René Descartes, Université Paris Descartes; Service de Médecine Interne, UF d'Hématologie
,
Sylvain Choquet Université Paris VI; Service d'Hématologie, Hôpital Pitié-Salpêtrière, Paris, France
,
François Dreyfus Faculté de Médecine René Descartes, Université Paris Descartes; Service de Médecine Interne, UF d'Hématologie
&
Didier Bouscary Faculté de Médecine René Descartes, Université Paris Descartes; Service de Médecine Interne, UF d'Hématologie
 show all
Pages 2012-2014 | Received 04 May 2008, Accepted 17 Jun 2008, Published online: 01 Jul 2009

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Chadi Al-nawakil, Olivier Kosmider, Marc-Henri Stern, Elodie Manié, ValéRIE Bardet, VéRonique Leblond, Sophie Park, FrançOIS Dreyfus, Didier Bouscary & Jerome Tamburini. (2011) Leukemic phase of follicular lymphomas: an atypical presentation. Leukemia & Lymphoma 52:8, pages 1504-1508.
Read now
Michaela Liedtke & Bruno C Medeiros. (2010) Plasma cell leukemia: concepts and management. Expert Review of Hematology 3:5, pages 543-549.
Read now

Articles from other publishers (19)

Matilda Ong’ondi & Elizabeth Kagotho. (2021) Plasma Cell Leukemia: A Review of 3 Cases Managed in Kenya. Case Reports in Hematology 2021, pages 1-6.
Crossref
Sam Ngu, Divya Asti, Gautam Valecha, Nishitha Thumallapally, Manisha Pant & Alexander Bershadskiy. (2019) Primary plasma cell leukemia: A case report and review of the literature. Clinical Case Reports 7:9, pages 1702-1708.
Crossref
Bruno RoyerStéphane MinvielleMomar DioufMurielle RousselLionel KarlinCyrille HulinBertrand ArnulfMargaret MacroSylvie CailleresAnnie BrionSabine BrechignacKarim BelhadjMarie Lorraine ChretienMarc WetterwaldCarine ChaleteixMourad TiabXavier LeleuLaurent FrenzelLaurent GarderetSylvain ChoquetJean Gabriel FuzibetCharles DauriacLuc-Matthieu FornekerLotfi BenboubkerThierry FaconPhilippe MoreauHervé Avet-LoiseauJean Pierre Marolleau. (2016) Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du Myélome. Journal of Clinical Oncology 34:18, pages 2125-2132.
Crossref
Pellegrino Musto, Vittorio Simeon, Katia Todoerti & Antonino Neri. (2016) Primary Plasma Cell Leukemia: Identity Card 2016. Current Treatment Options in Oncology 17:4.
Crossref
Jacob Laubach & Shaji Kumar. 2016. Plasma Cell Dyscrasias. Plasma Cell Dyscrasias 145 167 .
Tomas Jelinek, Fedor Kryukov, Lucie Rihova & Roman Hajek. (2015) Plasma cell leukemia: from biology to treatment. European Journal of Haematology 95:1, pages 16-26.
Crossref
Taiga Nishihori, Sarah M. Abu Kar, Rachid Baz, Melissa Alsina, Jean-Luc Harousseau & Mohamed A. Kharfan-Dabaja. (2013) Therapeutic Advances in the Treatment of Primary Plasma Cell Leukemia: A Focus on Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation 19:8, pages 1144-1151.
Crossref
Priya Mary Jacob, Rekha A Nair, Jayasudha A V, Sindhu Nair P & Anila K R. (2013) Downregulation of CD10 in leukaemic phase of follicular lymphoma: a silent deception. Journal of Hematopathology 6:2, pages 65-70.
Crossref
C Fernández de Larrea, R A Kyle, B G M Durie, H Ludwig, S Usmani, D H Vesole, R Hajek, J F San Miguel, O Sezer, P Sonneveld, S K Kumar, A Mahindra, R Comenzo, A Palumbo, A Mazumber, K C Anderson, P G Richardson, A Z Badros, J Caers, M Cavo, X LeLeu, M A Dimopoulos, C S Chim, R Schots, A Noeul, D Fantl, U-H Mellqvist, O Landgren, A Chanan-Khan, P Moreau, R Fonseca, G Merlini, J J Lahuerta, J Bladé, R Z Orlowski & J J Shah. (2012) Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. Leukemia 27:4, pages 780-791.
Crossref
Niels W. C. J. van de Donk, Henk M. Lokhorst, Kenneth C. Anderson & Paul G. Richardson. (2012) How I treat plasma cell leukemia. Blood 120:12, pages 2376-2389.
Crossref
G. D'Arena, C.G. Valentini, G. Pietrantuono, R. Guariglia, M.C. Martorelli, G. Mansueto, O. Villani, D. Onofrillo, A. Falcone, G. Specchia, G. Semenzato, N. Di Renzo, L. Mastrullo, A. Venditti, F. Ferrara, A. Palumbo, L. Pagano & P. Musto. (2012) Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party. Annals of Oncology 23:6, pages 1499-1502.
Crossref
A Mahindra, M E Kalaycio, J Vela-Ojeda, D H Vesole, M-J Zhang, P Li, J R Berenson, J M Bird, A Dispenzieri, J L Gajewski, R P Gale, L Holmberg, S Kumar, R A Kyle, H M Lazarus, S Lonial, J Mikhael, G A Milone, R Munker, R Nath, S Saccaro, L Bik To, D T Vogl, B Wirk & P Hari. (2011) Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research. Leukemia 26:5, pages 1091-1097.
Crossref
Pellegrino Musto, Livio Pagano, Maria Teresa Petrucci, Fortunato Morabito, Tommaso Caravita, Francesco Di Raimondo, Luca Baldini, Patrizia Tosi, Sara Bringhen, Massimo Offidani, Paola Omede’, Antonino Neri, Fiorella D’Auria, Giovanni Battista Bochicchio, Michele Cavo, Mario Boccadoro & Antonio Palumbo. (2012) Primary plasma cell leukemia in the era of new drugs: Has something changed?. Critical Reviews in Oncology/Hematology 82:2, pages 141-149.
Crossref
L. Pagano, C.G. Valentini, V. De Stefano, A. Venditti, G. Visani, M.T. Petrucci, A. Candoni, G. Specchia, C. Visco, E.M. Pogliani, F. Ferrara, P. Galieni, A. Gozzetti, L. Fianchi, M. De Muro, G. Leone, P. Musto & A. Pulsoni. (2011) Primary plasma cell leukemia: a retrospective multicenter study of 73 patients. Annals of Oncology 22:7, pages 1628-1635.
Crossref
Flavio Albarracin & Rafael Fonseca. (2011) Plasma cell leukemia. Blood Reviews 25:3, pages 107-112.
Crossref
Caterina Giovanna Valentini, Valentina Bozzoli, Luana Fianchi, Maria Teresa Voso, Gianluigi Di Paolantonio, Marianna Criscuolo, Giuseppe Leone, Luigi Maria Larocca & Livio Pagano. (2011) Primary plasma cell leukemia followed by testicular plasmacytoma. International Journal of Hematology 93:2, pages 224-227.
Crossref
Edward Libby, Dulcinea Candelaria‐Quintana, Hayan Moualla, Maryam Abdul‐Jaleel & Ian Rabinowitz. (2010) Durable complete remission of primary plasma cell leukemia with the bortezomib plus melphalan and prednisone (VMP) regimen. American Journal of Hematology 85:9, pages 733-734.
Crossref
Steven M Chan, Tracy George, Athena M Cherry & Bruno C Medeiros. (2009) Complete remission of primary plasma cell leukemia with bortezomib, doxorubicin, and dexamethasone: a case report. Cases Journal 2:1.
Crossref
Victor H. Jimenez-Zepeda & Virginia J. Dominguez-Martinez. (2009) Plasma cell leukemia: a highly aggressive monoclonal gammopathy with a very poor prognosis. International Journal of Hematology 89:3, pages 259-268.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.